News|Articles|November 17, 2026

WHO Reports 2 MERS Cases in Qatar, First Since 2022

The World Health Organization (WHO) confirmed 2 sporadic, camel-linked MERS-CoV infections with both patients recovered and no secondary transmission among 99 traced contacts.

The World Health Organization (WHO) announced 2 laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Qatar, the country’s first MERS cases since 2022.¹ Qatar’s International Health Regulations National Focal Point notified WHO on October 29, 2026, and WHO published its Disease Outbreak News report on November 13.¹ Both patients had occupational exposure to dromedary camels, and both recovered.¹

The Qatar cases arrive as global MERS-CoV detection sits near historic lows. As of September 29, 2026, the European Centre for Disease Prevention and Control (ECDC) counted 2,649 MERS cases and 960 deaths reported worldwide since April 2012.³ ECDC noted new case detection through surveillance has fallen to its lowest level since 2014.³

Both patients were men older than 50 years with underlying chronic conditions, and the 2 cases had no epidemiologic link.¹ The first patient developed symptoms on July 22, 2026, after long-term work with camels, including during the 14 days before onset. His initial upper respiratory polymerase chain reaction (PCR) test was negative, but a lower respiratory specimen confirmed infection on August 5.¹

The second patient, who bred and reared camels, developed symptoms on August 23 after caring for recently ill young camels and drinking raw camel milk.¹ He progressed to severe pneumonia with acute hypoxemic respiratory failure requiring high-flow nasal oxygen and noninvasive ventilation. Both patients were discharged in stable condition after two consecutive negative PCR tests.¹

Health authorities traced 99 contacts, including 84 health and care workers, and all tested negative.¹ One health worker exposed to the second patient developed respiratory symptoms but tested negative on two specimens. WHO considers the cases sporadic zoonotic spillover and keeps its overall regional and global risk assessment at moderate.¹

WHO advises clinicians to include MERS-CoV in testing for patients with compatible illness and camel exposure, unexplained severe respiratory infection, or unusual clusters.¹ The agency also recommends airborne precautions during aerosol-generating procedures for suspected or confirmed cases. WHO advises against travel or trade restrictions on affected countries.¹

What You Need to Know

Both cases involved men older than 50 years with chronic conditions and occupational dromedary camel exposure, and one also drank raw camel milk.

One patient tested negative on an upper respiratory PCR specimen, and infection was confirmed only through lower respiratory sampling.

CDC reports no specific antiviral or vaccine for MERS, a case fatality rate of 30% to 40%, and a very low current risk to the US public

MERS: Transmission, Symptoms, and Treatment

The Centers for Disease Control and Prevention (CDC) describes MERS as a viral respiratory illness caused by MERS-CoV, with most cases detected in or near the Arabian Peninsula.² The virus spreads from dromedary camels to people through close contact, and limited person-to-person spread can occur in households, during travel, and in health care facilities. The largest outbreak outside the Arabian Peninsula occurred in the Republic of Korea in 2015.²

Symptoms typically appear five or six days after exposure, with a range of two to 14 days.² Fever, cough, and shortness of breath predominate, and some patients report diarrhea, nausea, or vomiting. Most reported cases developed pneumonia, and kidney failure has also occurred.²

CDC estimates 30% to 40% of reported patients with MERS have died, most with at least one preexisting medical condition.² Older age, chronic heart, kidney, or lung disease, diabetes, and certain cancers raise the risk of severe complications. No specific antiviral treatment is recommended, no vaccine is available, and management remains supportive.²

Only 2 patients in the United States have ever tested positive for MERS-CoV, both travel-associated cases in May 2014 involving health care providers who had worked in Saudi Arabia.² CDC considers the current risk to the general US public very low and does not recommend changing travel plans. The agency advises patients with fever or respiratory symptoms to report recent travel to the Arabian Peninsula, camel contact, or exposure to a person with MERS.²

Contagion has also tracked the broader merbecovirus threat. In February 2025, and reported on HKU5-CoV-2, a bat merbecovirus related to MERS-CoV, which investigators found can use human ACE2 for cell entry and infect human respiratory and enteric organoids.⁴ The study authors warned of a high spillover risk, though further research is needed to define it.⁴

WHO continues to call for coordinated One Health investigations, enhanced camel surveillance, and prompt data sharing among affected countries.¹ The agency also advises people with chronic conditions or weakened immune systems to avoid close contact with camels and camel products.¹


References
  1. World Health Organization. Middle East respiratory syndrome (MERS), Qatar. Disease Outbreak News. November 13, 2026. Accessed November 17, 2026. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON626
  2. Centers for Disease Control and Prevention. About Middle East respiratory syndrome (MERS). Accessed November 17, 2026. https://www.cdc.gov/coronavirus/mers/
  3. European Centre for Disease Prevention and Control. MERS-CoV worldwide overview: situation update, 29 September 2026. Accessed November 17, 2026. https://www.ecdc.europa.eu/en/middle-east-respiratory-syndrome-coronavirus-mers-cov-situation-update
  4. Parkinson J. New bat coronavirus has capacity to spread to humans. Contagion. February 21, 2025. Accessed November 17, 2026. https://www.contagionlive.com/view/new-bat-coronavirus-has-capacity-to-spread-to-humans

Related to this article

Measles Update: November 13, 2026
The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.